Company news
Pasithea Therapeutics Corp. news in 2022
Pasithea Therapeutics Corp.'s news releases, calls and decks from 2022, newest first.
Majority of Stockholders Support Pasithea Directors at Special Meeting
December 13, 2022
Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group
December 11, 2022
Pasithea Therapeutics to Present at Annual Meeting of the Antibody Society Conference
December 5, 2022
Pasithea Therapeutics Postpones Special Meeting until December 9, 2022 at 9: 00 AM Eastern Time
November 27, 2022
Pasithea Therapeutics to Present Tolerizing Vaccine Program Results at Immunotherapy 2022 International Course and Symposium
October 16, 2022
Pasithea Therapeutics Acquires AlloMek Therapeutics
October 11, 2022
Pasithea Therapeutics to Call Special Meeting of Stockholders
October 2, 2022
Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors
September 19, 2022
Pasithea Therapeutics Further Strengthens its Scientific Advisory Board with the Appointment of Dr. Merit Cudkowicz
September 14, 2022
Pasithea Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 8, 2022
Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference
August 17, 2022
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis
August 10, 2022
Pasithea Therapeutics Urges Stockholders to Reject Activist Camac Group’s Unjustified Campaign
August 1, 2022
Pasithea Therapeutics Awarded a Drug Development Research Grant
July 13, 2022
Pasithea Therapeutics to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond
June 22, 2022
Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC
June 21, 2022
Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022
April 13, 2022
Pasithea Therapeutics Announces Financial and Business Results for the Fourth Quarter and Full Year 2021 and Business Update for 2022
March 29, 2022
Pasithea Therapeutics Announces Collaboration with The Glimpse Group
March 7, 2022
Pasithea Therapeutics Announces Plans to Open Three New Clinics in the UK by Mid-2022
February 23, 2022
Pasithea Therapeutics Strengthens its Scientific Advisory Board with the Appointment of Preeminent Scientist Dr. Daniel Weinberger
February 8, 2022
Pasithea Therapeutics Initiates New Chemical Entity Drug Development Program in Multiple Sclerosis
February 2, 2022
Pasithea Therapeutics Announces Opening of Mental Health Clinic in Los Angeles and Broadens Focus Beyond Ketamine Treatments
January 25, 2022